Close menu

February 9th, 2023 | 19:54 CET

Comeback opportunity or a complete washout? These facts decide: Deutsche Bank, K+S, Tocvan Ventures

  • Mining
  • Gold
  • Investments
Photo credits:

Various sectors have enjoyed a boom in recent months. Commodity companies benefited from rising prices, and banks from higher interest rates. But the trees do not grow to the sky even for stocks favoured by the market. Every trend comes to an end. Where investors can believe in comebacks and where uneasiness could threaten - we take a close look for you!

time to read: 3 minutes | Author: Nico Popp
ISIN: DEUTSCHE BANK AG NA O.N. | DE0005140008 , K+S AG NA O.N. | DE000KSAG888 , TOCVAN VENTURES C | CA88900N1050

Table of contents:

    Justin Reid, President and CEO, Troilus Gold Corp.
    "[...] Troilus has the potential to be an entire gold belt. All of our work to date points to this, and each drill hole makes the picture we have of the Troilus project much clearer. [...]" Justin Reid, President and CEO, Troilus Gold Corp.

    Full interview


    Deutsche Bank: This is the predicament

    Deutsche Bank's stock has been in the headlines lately. The latest quarterly figures were less good than expected. Even discussions about a share buyback program could not boost the share again. The reason: Analysts had speculated that the shape of the price of cosmetics could be in danger this year. At the same time, media reports about high derivative holdings around precious metals in the balance sheets of US banks are doing the rounds. Also, the bank supervisors of the European Central Bank warned banks on Tuesday to be careful. The risks in connection with the Ukraine war are not yet off the table. Banks should therefore focus on precautionary measures. So is the banking crisis back?

    Instead of waiting for black swans as an investor, it is better to look at the interest rate environment in connection with banks. Central banks in major currency areas have recently taken smaller interest rate steps. An interest rate pause in the second quarter seems possible, and even interest rate cuts are conceivable again from 2024. Exogenous shocks could trigger interest rate cuts, but a latent risk of recession - provided inflation has been reliably averted by then - could also provide grounds for consistent action by central banks. In either scenario, bank shares could come under pressure: A recession weighs on the lending business, and falling interest rates also shrink the scope for banks. After six successful months, Deutsche Bank shareholders can slowly but surely return to a focus on protecting their profits.

    Tocvan Ventures: Financed gold prospector with cost advantages

    Hedging can also be the focus of the shares of Tocvan Ventures - although the term initially seems inappropriate in connection with the smallcap from Canada. Tocvan Ventures operates two promising gold projects in northern Mexico, Pilar and El Picacho. The region is particularly popular for its low-cost heap leach process. This process allows even smaller deposits to be exploited profitably. In general, the Company, in the person of CEO Brodie Sutherland, emphasizes the good general conditions: "The costs for exploration are also significantly lower. For example, we pay around CAD 50 per meter for drilling. Elsewhere, this amount is significantly higher. The bottom line is that our costs are about 25% lower than in other well-known mining regions," the manager said in an interview last summer.

    At that time, in addition to encouraging drilling results, Tocvan Ventures also made a splash with the entry of investor Sorbie Bornholm. The investment secures the Company's financing until 2024 and allows the Company to focus on its core task of exploration. Sorbie Bornholm is known for its strategic support of projects and has, in the past, gradually increased its involvement in companies. The shares of Tocvan Ventures are a flawless small cap with a market capitalization of only CAD 22.6 million. The charm of two promising gold projects, of which El Picacho is very similar to the nearby San Francisco mine, could make the stock attractive as an addition and for investors in turbulent times.

    K+S: New record prices quesitonable

    Two years ago, the K+S share was also considered exciting - inflation was in the starting blocks and K+S anticipated this development. Today, the share has already experienced a positive development. Although analysts have recently raised their expectations again, the potential appears limited despite good underlying conditions. The business is considered cyclical. Weaknesses in the upcoming quarterly figures could make investors sit up and take notice. As K+S has recently broadened its supply chains, risks in connection with the Ukraine war should be lower today. However, it seems questionable whether the share will reach record prices again.

    Demographics alone support K+S - but is that enough? Source: K+S AG

    The gears are sputtering at both Deutsche Bank and K+S. The former profiteers of inflation and the interest rate turnaround have to face the new realities. Higher valuation levels also make further price gains seem less likely. As a small cap, the Tocvan Ventures share is not without risk, but the external factors here are almost exclusively limited to financing risk. Thanks to investor Sorbie Bornholm, the Company is financed until mid-2024. Operationally, there is room for surprises.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by Nico Popp on September 28th, 2023 | 09:05 CEST

    Germany - Car Country? The exodus begins: Mercedes-Benz, Volkswagen, First Phosphate

    • Mining
    • phosphate
    • Electromobility
    • Energy

    Cars still play a significant role in Germany. Many households have two vehicles, some even more. However, sales of new cars have weakened recently - the question of whether to buy a combustion engine or an electric vehicle, along with inflation, have deterred many buyers. German brand manufacturers are now being attracted to the US. There, they are enticed by subsidies and an intact market. Find out what the latest plans of Mercedes-Benz, Volkswagen, and others entail and which relatively unknown company could benefit.


    Commented by André Will-Laudien on September 28th, 2023 | 08:05 CEST

    Attention: Extended correction - Buy the right stocks now! Bayer, Viva Gold, TUI, and BASF are on the list!

    • Mining
    • Gold
    • Pharma
    • chemicals
    • travel

    Higher inflation and rising interest rates - this connection should be clear to investors. The interest rate level in Germany has moved from negative territory to 2.77% in the 10-year range, but stocks continued to rise cheerfully. The party led to all-time highs of 16,528 points in July, but the fundamental situation of the companies deteriorated in parallel. Only after repeated warnings from the US Federal Reserve did the explosive NASDAQ also enter a correction. And it continues. Yesterday, the CEO of US investment bank JPMorgan, Dimon, warned that the world may not be prepared for 7% capital market interest rates. He and Dr. Jens Erhardt, the CEO of the asset management company DJE, warn of stronger setbacks on the stock markets. Some stocks have already undergone a strong correction. Here is a brief overview.